Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valganciclovir in Neonates With Symptomatic Congenital Cytomegalovirus (CMV) Infection
NCT00031434Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jul 2002
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valganciclovir in cytomegalovirus infection (CMV), sponsored by National Institute of Allergy and Infectious Diseases. Started Jul 2002; status: completed.
02
Drugs
valganciclovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT00031434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00031434.